PPA
VSTM icon

Parametric Portfolio Associates’s Verastem VSTM Stock Holding History

Parametric Portfolio Associates’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$56K Sell
3,318
-2,372
-42% -$40.8K ﹤0.01% 3623
2021
Q4 		$140K Sell
5,690
-983
-15% -$31K ﹤0.01% 3498
2021
Q3 		$247K Buy
6,673
+3,351
+101% +$123K ﹤0.01% 3369
2021
Q2 		$162K Buy
+3,322
New +$138K ﹤0.01% 3435
2019
Q2 		– Sell
-1,574
Closed -$56K – 4006
2019
Q1 		$56K Sell
1,574
-384
-20% -$15.2K ﹤0.01% 3881
2018
Q4 		$79K Buy
+1,958
New +$120K ﹤0.01% 3806
2018
Q3 		– Sell
-14,824
Closed -$1.22M – 3973
2018
Q2 		$1.22M Buy
14,824
+13,759
+1,292% +$842K ﹤0.01% 2949
2018
Q1 		$38K Buy
1,065
+27
+3% +$1.05K ﹤0.01% 3913
2017
Q4 		$38K Buy
+1,038
New +$46.9K ﹤0.01% 3881
2016
Q1 		– Sell
-6,861
Closed -$153K – 4038
2015
Q4 		$153K Buy
+6,861
New +$163K ﹤0.01% 3795
2015
Q1 		– Sell
-1,360
Closed -$149K – 4007
2014
Q4 		$149K Buy
1,360
+312
+30% +$33.7K ﹤0.01% 3849
2014
Q3 		$107K Buy
+1,048
New +$110K ﹤0.01% 3717

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Parametric Portfolio Associates's VSTM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Verastem (VSTM) stake by 42% in Q1 2022, selling an estimated $40.8K and leaving 3,318 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #3623.

Parametric Portfolio Associates first reported a position in VSTM in Q3 2014 and has held it in 12 quarters since. The position peaked at $1.22M in Q2 2018. 141 funds tracked by Wall St. Rank hold VSTM as of Q1 2022.

  • Parametric Portfolio Associates held 3,318 shares of Verastem worth $56K as of Q1 2022.
  • Parametric Portfolio Associates sold 2,372 Verastem shares in Q1 2022, an estimated $40.8K.
  • Verastem made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3623 holding.
  • Parametric Portfolio Associates first reported a position in Verastem in Q3 2014 and has held it in 12 quarters since.
  • Parametric Portfolio Associates's Verastem position peaked at $1.22M in Q2 2018.
  • 141 funds tracked by Wall St. Rank held Verastem as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.